Clinical Trial Update: Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 dose-finding feasibility trial of Optison for contrast-enhanced ultrasound in detecting carotid artery disease; the study was terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Disease

Drugs mentioned

• Optison

Snippet

Sponsor: GE Healthcare | Conditions: Carotid Artery Disease | Phase 2 | Status: TERMINATED | Results posted: 2014-04-16